By David Eagleman — 2013
After President Obama’s recent announcement of a plan to invigorate the study of neuroscience with what could amount to a $3 billion investment, a reasonable taxpayer might ask: Why brain science? Why now?
Read on www.nytimes.com
CLEAR ALL
Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.
1